14115-06-1 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-(dimethylamino)propoxy)-5-(trifluoromethyl)benzenamine is used as an intermediate in the synthesis of pharmaceutical compounds for its potential medicinal properties. The presence of the trifluoromethyl group and the amine functionality can be exploited to create new drugs with specific therapeutic effects.
Used in Chemical Synthesis:
In the chemical synthesis industry, 2-(3-(dimethylamino)propoxy)-5-(trifluoromethyl)benzenamine serves as a key building block for the creation of more complex organic molecules. Its functional groups can participate in various reactions, such as substitution, addition, or condensation, to form a wide range of products.
Used in Material Science:
2-(3-(dimethylamino)propoxy)-5-(trifluoromethyl)benzenamine is used as a component in the development of new materials with specific properties. Its structural features can influence the physical and chemical characteristics of the resulting materials, making it suitable for applications in coatings, polymers, or other advanced materials.
Used in Research and Development:
In the field of research and development, 2-(3-(dimethylamino)propoxy)-5-(trifluoromethyl)benzenamine is utilized as a model compound to study the effects of structural modifications on chemical behavior and reactivity. This can lead to a better understanding of organic chemistry and the discovery of new reaction mechanisms or applications.
Check Digit Verification of cas no
The CAS Registry Mumber 14115-06-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,1,1 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 14115-06:
(7*1)+(6*4)+(5*1)+(4*1)+(3*5)+(2*0)+(1*6)=61
61 % 10 = 1
So 14115-06-1 is a valid CAS Registry Number.
14115-06-1Relevant academic research and scientific papers
SEMICARBAZIDE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 220, (2008/06/13)
The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
PROTEIN KINASE MODULATORS AND METHOD OF USE
-
Page/Page column 101, (2010/02/14)
The present invention relates to chemical compounds having a general formula I wherein A, B, D, E, G, H1-5 and R1-4 are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of these kinases. For example, the compounds are capable of modulating kinase enzymes thereby influencing the process of angiogenesis and treating angiogenesis-related diseases and other poliferative disorders, including cancer and inflammation. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of protein kinases.
